Intrauterine Devices (IUD) Market | Growth, Trends And Forecast, 2024

 
 
Spread the Word
Listed Under

Tag:
* Intrauterine Devices Market

Industry:
* Health

Location:
* New York City - New York - US

Subject:
* Products

NEW YORK - Jan. 14, 2020 - PRLog -- As per the latest report by IMARC Group, titled "Intrauterine Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024", the global intrauterine devices market reached a value of US$ 3.83 Billion in 2018. Intrauterine devices (IUDs) are small T-shaped contraceptive devices which are inserted into the uterus. The copper or hormones present in these devices alters the cervical mucus lining which prevents fertilization. Intrauterine devices are usually a form of long-acting reversible contraceptives (LARC) which aid in birth control for an extended period and can last for 5 to 10 years, depending on the type. They have minimal side effects when compared to other methods of contraception and are associated with less discomfort.

Market Trends:

Unintended pregnancies and unplanned births can pose a major threat to the health of a woman. Increasing rates of unexpected pregnancies across the globe are leading women to use contraceptive methods like IUDs as a precautionary measure, thereby spurring the growth of the market. Another trend that has been witnessed among the women in developed countries is delaying pregnancy until their thirties. Due to their reversible nature, intrauterine devices are being preferred by these women as the primary method of contraception. Further, NGOs such as The International Federation of Gynaecology and Obstetrics (FIGO) are working towards improving women's health by addressing the high maternal mortality rates in low?resource countries and encouraging women to make informed decisions about effective contraceptive methods. An increasing number of initiatives by such organizations is anticipated to propel the demand for intrauterine devices. Due to these factors, the market value is estimated to reach US$ 4.74 Billion by 2024, expanding at a CAGR of 3.6% during 2019-2024.

Request for a free sample copy of this report: https://www.imarcgroup.com/intrauterine-devices-market/requestsample

Insights on Market Segmentation:

Market Breakup by Product:


1. Hormonal Intrauterine Device

2. Copper Intrauterine Device

Browse full report with detailed TOC and list of figures and tables: https://www.imarcgroup.com/intrauterine-devices-market

Market Breakup by End-Use:

1. Hospitals

2. Gynaecology Clinics

3. Community Healthcare

4. Others

Market Breakup by Region:

1. Europe

2. North America

3. Asia Pacific

4. Middle East and Africa

5. Latin America

Competitive Landscape:

Some of the key players operating in the market include Actavis, Bayer, Teva Pharmaceuticals, Allergan, ANI Pharmaceuticals, Eurogine, OCON Medical, Pregna, SMB Corporation, HLL Lifecare, HRA Pharma and Besins HealthCare.

Contact Us

IMARC Group
Email:
sales@imarcgroup.com
Phone No: (D) +91 120 433 0800 | www.imarcgroup.com
Americas :- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331
End
Email:***@gmail.com
Phone:6317911145
Tags:Intrauterine Devices Market
Industry:Health
Location:New York City - New York - United States
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
IMARC Group News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share